Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CC chemokines and receptors in osteoarthritis: new insights and potential targets. | Arthritis Res Ther | 2023 | 37400871 | PubTator, text mining | PubMed |
| Cell surface nucleocapsid protein expression: A betacoronavirus immunomodulatory strategy. | Proc Natl Acad Sci U S A | 2023 | 37399385 | PubTator, text mining | PubMed |
| Prognostic Role of CD68+ and CD163+ Tumour-Associated Macrophages and PD-L1 Expression in Oral Squamous Cell Carcinoma: A Meta-Analysis. | Br J Biomed Sci | 2023 | 37397243 | PubTator, text mining | PubMed |
| Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis? | Cell Mol Life Sci | 2023 | 37395809 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37383234 | PubTator, text mining | PubMed |
| Sequential Application and Post-Test Probability for Screening of Bladder Cancer Using Urinary Proteomic Biomarkers: A Review based Probabilistic Analysis. | Asian Pac J Cancer Prev | 2023 | 37378932 | PubTator, text mining | PubMed |
| Air Pollution and microRNAs: The Role of Association in Airway Inflammation. | Life (Basel) | 2023 | 37374157 | PubTator, text mining | PubMed |
| Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers. | Int J Mol Sci | 2023 | 37373339 | PubTator, text mining | PubMed |
| An In Vitro Alveolar Model Allows for the Rapid Assessment of Particles for Respiratory Sensitization Potential. | Int J Mol Sci | 2023 | 37373252 | PubTator, text mining | PubMed |
| Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications. | Biology (Basel) | 2023 | 37372147 | PubTator, text mining | PubMed |
| Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers. | Antioxidants (Basel) | 2023 | 37371940 | PubTator, text mining | PubMed |
| Recent Advances in CAR-Based Solid Tumor Immunotherapy. | Cells | 2023 | 37371075 | PubTator, text mining | PubMed |
| In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients. | Cancers (Basel) | 2023 | 37370765 | PubTator, text mining | PubMed |
| The effects of pulmonary rehabilitation on inflammatory biomarkers in patients with chronic obstructive pulmonary disease: Protocol for a systematic review and meta-analysis. | PLoS One | 2023 | 37368891 | PubTator, text mining | PubMed |
| New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions. | Cancer Metastasis Rev | 2023 | 37368179 | PubTator, text mining | PubMed |
| Influence of macrophage polarization in herniated nucleus pulposus tissue on clinical efficacy after lumbar discectomy. | JOR Spine | 2023 | 37361327 | PubTator, text mining | PubMed |
| When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis. | Front Immunol | 2023 | 37359516 | PubTator, text mining | PubMed |
| Prevention of M2 polarization and temporal limitation of differentiation in monocytes by extracellular ATP. | BMC Immunol | 2023 | 37353774 | PubTator, text mining | PubMed |
| Spatial transcriptomics: Technologies, applications and experimental considerations. | Genomics | 2023 | 37353093 | PubTator, text mining | PubMed |
| Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review. | Strahlenther Onkol | 2023 | 37347290 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=31